» Articles » PMID: 38594706

Prevalence of Menthol Cigarette Use Among Adults Who Smoke from the United States by Census Division and Demographic Subgroup, 2002-2020: Findings from the International Tobacco Control (ITC) Project

Overview
Publisher Biomed Central
Specialty Public Health
Date 2024 Apr 9
PMID 38594706
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Targeted marketing of menthol cigarettes in the US influences disparities in the prevalence of menthol smoking. There has been no analysis of sub-national data documenting differences in use across demographic subgroups. This study estimated trends in the prevalence of menthol use among adults who smoke in the nine US census divisions by sex, age, and race/ethnicity from 2002 to 2020.

Methods: Data from 12 waves of the US ITC Survey were used to estimate the prevalence of menthol cigarette use across census divisions and demographic subgroups using multilevel regression and post-stratification (n = 12,020). Multilevel logistic regression was used to predict the prevalence of menthol cigarette use in 72 cross-classified groups of adults who smoke defined by sex, age, race/ethnicity, and socioeconomic status; division-level effects were fit with a random intercept. Predicted prevalence was weighted by the total number of adults who smoke in each cross-classified group and aggregated to divisions within demographic subgroup. Estimates were validated against the Tobacco Use Supplement to the Current Population Survey (TUS-CPS).

Results: Overall modeled prevalence of menthol cigarette use was similar to TUS-CPS estimates. Prevalence among adults who smoke increased in each division from 2002 to 2020. By 2020, prevalence was highest in the Middle (46.3%) and South Atlantic (42.7%) and lowest in the Pacific (25.9%) and Mountain (24.2%) divisions. Prevalence was higher among adults aged 18-29 (vs. 50+) and females (vs. males). Prevalence among non-Hispanic Black people exceeded 80% in the Middle Atlantic, East North Central, West North Central, and South Atlantic in all years and varied most among Hispanic people in 2020 (Pacific: 26.5%, New England: 55.1%).

Conclusions: Significant geographic variation in the prevalence of menthol cigarette use among adults who smoke suggests the proposed US Food and Drug Administration (FDA) menthol cigarette ban will exert differential public health benefits and challenges across geographic and demographic subgroups.

References
1.
Mokdad A . The Behavioral Risk Factors Surveillance System: past, present, and future. Annu Rev Public Health. 2009; 30:43-54. DOI: 10.1146/annurev.publhealth.031308.100226. View

2.
Zhang X, Holt J, Lu H, Wheaton A, Ford E, Greenlund K . Multilevel regression and poststratification for small-area estimation of population health outcomes: a case study of chronic obstructive pulmonary disease prevalence using the behavioral risk factor surveillance system. Am J Epidemiol. 2014; 179(8):1025-33. DOI: 10.1093/aje/kwu018. View

3.
Mills S, Peddireddy S, Kurtzman R, Hill F, Catalan V, Bissram J . The Impact of Menthol Cigarette Bans: A Systematic Review and Meta-Analysis. Nicotine Tob Res. 2024; 27(2):179-191. PMC: 11750744. DOI: 10.1093/ntr/ntae011. View

4.
Agaku I, Odani S, Okuyemi K, Armour B . Disparities in current cigarette smoking among US adults, 2002-2016. Tob Control. 2019; 29(3):269-276. DOI: 10.1136/tobaccocontrol-2019-054948. View

5.
Licht A, Hyland A, OConnor R, Chaloupka F, Borland R, Fong G . Socio-economic variation in price minimizing behaviors: findings from the International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health. 2011; 8(1):234-52. PMC: 3037072. DOI: 10.3390/ijerph8010234. View